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ASSESSING THE ROLE OF BONE MORPHOGENETIC PROTEIN-2 (BMP2) IN 
VESSEL FORMATION DURING DISTRACTION OSTEOGENESIS 
ABIGAIL H. CLARK 
ABSTRACT 
 Bone Morphogenetic Protein 2 (BMP2) is a growth factor needed to initiate 
fracture repair and is involved in the differentiation of progenitor cells to the 
osteochondral lineage. Osteogenesis and angiogenesis are coupled processes, however 
the mechanism by which these processes are coupled and the role that BMP2 plays in 
coupling these processes is not well understood. In distraction osteogenesis, a bone 
regeneration model mediated by mechanical distraction of an osteotomy, BMP2 
expression was primarily associated with blood vessels. Therefore, transgenic mice were 
used to conditionally delete BMP2 expression (BMP2-cKO) in smooth muscle cells 
during distraction osteogenesis to identify the role of BMP2 in osteogenesis and 
angiogenesis. Vessel formation was characterized by vascular perfusion of animals with a 
barium-gelatin solution, which was used as a radiographic contrast agent that allowed 
vessel formation to be quantified by micro-computer assisted tomography (µCT). Using 
the same transgenic mice to label those cells in which BMP2 had been deleted, 
histological analysis was performed to confirm the targeting specificity of the BMP2-
cKO. µCT analysis showed less bone formation occurred in the BMP2-cKO animals 
compared to controls. The µCT analysis further showed vessel volume and thickness 
were decreased in BMP2-cKO animals at both day 17 and 31, suggesting that there is a 
relationship between BMP2 and vessel size. Vessel number was greater in controls than 
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the BMP2-cKO animals at day 17, however the BMP2-cKO animals had a larger vessel 
number than the number by day 31. Histological analysis confirmed knockout of BMP2 
expression in smooth muscle cells, as well as in skeletal muscle and chondrocytes. These 
results suggest the importance of BMP2, not only in bone formation, but also in vessel 
morphogenesis.  
  
	  	   vii 
TABLE OF CONTENTS 
 
TITLE……………………………………………………………………………………...i 
COPYRIGHT PAGE……………………………………………………………………...ii 
READER APPROVAL PAGE…………………………………………………………..iii 
ACKNOWLEDGMENTS .................................................................................................. iv	  
ABSTRACT ........................................................................................................................ v	  
TABLE OF CONTENTS .................................................................................................. vii	  
LIST OF TABLES .............................................................................................................. x	  
LIST OF FIGURES ............................................................................................................ xi	  
LIST OF ABBREVIATIONS ........................................................................................... xii	  
INTRODUCTION ............................................................................................................... 1	  
Bone Cells, Formation, and Metabolism ......................................................................... 1	  
Fracture Repair ................................................................................................................ 2	  
Distraction Osteogensis ................................................................................................... 3	  
The Role of Angiogenesis during Bone Repair .............................................................. 5	  
Bone Morphogenetic Proteins ......................................................................................... 7	  
Role of BMP2 during Distraction Osteogenesis ........................................................... 10	  
Experimental Aims ........................................................................................................ 11	  
METHODS ........................................................................................................................ 12	  
	  	   viii 
Animal Model ............................................................................................................... 12	  
List of Reagents Used ................................................................................................... 13	  
Distraction Osteogenesis Surgical Procedure ............................................................... 13	  
Distraction Procedure .................................................................................................... 14	  
Tamoxifen Preparation and Injections .......................................................................... 14	  
Barium Perfusion Procedure ......................................................................................... 15	  
MicroCT40 Scanning .................................................................................................... 16	  
Image Registration in AMIRA® ................................................................................... 17	  
Bone Tomography Evaluation ...................................................................................... 17	  
Histological Analysis .................................................................................................... 18	  
RESULTS .......................................................................................................................... 19	  
Cre-loxP System ............................................................................................................ 19	  
X-Ray ............................................................................................................................ 23	  
µCT Evaluations ............................................................................................................ 25	  
DISCUSSION ................................................................................................................... 31	  
APPENDIX ....................................................................................................................... 34	  
Scanco Evaluation Commands ...................................................................................... 34	  
Threshold Determination ....................................................................................... 34	  
Manual Evaluations ............................................................................................... 34	  
LIST OF JOURNAL ABBREVIATIONS ........................................................................ 35	  
REFERENCES .................................................................................................................. 37	  
	  	   ix 
CURRICULUM VITAE ................................................................................................... 43	  
 
  
	  	   x 
LIST OF TABLES 	  
Table Title Page 
1 Common reagents and equipment used for this study 13 
  
	  	   xi 
LIST OF FIGURES 
 
Figure Title Page 
1 Schematic of longitudinal section of bone during the 
phase of active distraction during DO 
4 
2 Schematic of VEGF's effects on angiogenesis and 
osteogenesis 
6 
3 Signaling pathways of Bone Morphogenetic Proteins 9 
4 Incisions performed prior to perfusion fixation 15 
5 Schematic of transgenic mouse model 20 
6 LacZ expression indicating knockout of BMP2 expression 
at POD 17 
21 
7 LacZ expression indicating knockout of BMP2 expression 
at POD 31 
22 
8 DO X-ray results 24 
9 Anterior views of co-registered bone and vessels from 
control animals 
25 
10 Anterior views of co-registered bone and vessels from 
BMP2-cKO animals 
26 
11 Comparison of vessels prior to (left) and after (right) 
component labeling 
27 
12 Volume of vessels (in mm3) surrounding distraction gap 28 
13 Thickness of vessels (in mm) surrounding the distraction 
gap 
29 
14 Number of vessels per unit length (1/mm) surrounding the 
distraction gap 
30 
	    
	  	   xii 
LIST OF ABBREVIATIONS 
αSMA .......................................................................................... alpha smooth muscle actin 
Ba .............................................................................................................................. Barium 
BMP2 .................................................................................. Bone Morphogenetic Protein-2 
DO ................................................................................................. Distraction Osteogenesis 
DICOM .............................................. Digital Imagining and Communications in Medicine 
EDTA ................................................................................... Etheylediaminetetraacetic acid 
ID-1 ................................................................................ Inhibitory Differentiation Factor-1 
ID-3 ................................................................................ Inhibitory Differentiation Factor-3 
IP .................................................................................................................... Intraperitoneal 
µCT ...................................................................................... Micro Computed Tomography 
PBS ............................................................................................... Phosphate buffered saline 
POD ......................................................................................................... Post-operative day 
ROI ........................................................................................................... Region of Interest 
TGFβ ................................................................................. Transforming growth factor beta 
VEGF .......................................................................... Vascular Endothelial Growth Factor 
VEGFR ......................................................... Vascular Endothelial Growth Factor Receptor 
w/w ........................................................................................................... weight per weight 
w/v ........................................................................................................... weight per volume 
 
	  1 
INTRODUCTION 
Bone Cells, Formation, and Metabolism 
Bone is a metabolically active tissue composed of a mineralized extracellular 
matrix that is continuously undergoing formation and resorption, a process known as 
bone remodeling. Three main cell types found in bone—osteoblasts, osteoclasts, and 
osteocytes contribute to this process (Mescher, 2016). Osteoblasts are specialized 
fibroblasts and are the primary bone forming cells (Shoback D, Sellmeyer D, Bikle D., 
2011). Osteoblasts secrete osteoid, the organic, unmineralized component of bone 
(Caetano-Lopes, Canhão, and Fonseca, 2007). Osteoid is composed primarily of dense 
type I collagen, but also includes glycoproteins and proteoglycans (Mescher, 2016). 
Later, osteoblasts mineralize the extracellular matrix by depositing hydroxyapatite 
(Karsenty, Kronenberg, and Settembre, 2009). Osteocytes are osteoblasts that have 
become embedded in the osteoid, but have cytoplasmic processes that extend into the 
matrix (Rochefort, Pallu, and Benhamou, 2010). They are connected to each other via the 
lacunar-canalicular network and relay mechanosensory information (Klein-Nulend, 
Nijweide, and Burger, 2003). Resorption is primarily carried out by osteoclasts, which 
are multinucleated cells. The mineral components of bone are solubilized by osteoclasts 
secreting protons and proteinases (Bringhurst et al., 2015).  
Bone formation occurs through one of two processes. Intramembranous 
ossification is the process by which mesenchymal cells differentiate into osteoblasts, 
which directly form bone. Ossification centers form within fibrous connective tissue and 
osteoblasts secrete organic extracellular matrix (Mescher, 2016). Flat bones, such as 
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cranial and facial bones, form by this process during development, while long bones 
develop through a process called endochondral ossification. Mesenchymal cells give rise 
to chondrocytes, which proliferate and form a cartilage matrix. Vessels penetrate the 
cartilage matrix, supplying osteoprogenitor cells and osteoclasts (Mackie et al., 2008). 
These osteoprogenitor cells differentiate into osteoblasts, which deposit mineral to form 
bone (Mescher, 2016).  
 
Fracture Repair 
Bone tissue is unique in the fact that it is one of only a few postnatal tissues 
capable to fully repair both original structure and composition. Fracture repair is one of 
the most studied mechanisms that recapitulates the developmental stages of endochondral 
ossification. Fracture repair occurs in two distinct phases. After fracture, a hematoma 
forms and there is an initial inflammatory response in which MSCs and osteoprogenitor 
cells are recruited and activated. Vasculature develops and supplies blood to the tissues. 
Signaling factors, such as Vascular Endothelial Growth Factor (VEGF), are expressed by 
cells in the perichondrium that may have angio-inductive effects (Riddle et al., 2009). 
Progenitor cells then differentiate into chondrocytes, which produce fibrocartilage, and 
osteoblasts, which produce woven bone. This process is concluded with remodeling—
resorption of cartilage and woven bone by osteoclasts and formation of mature bone 
(Einhorn & Gerstenfeld, 2005; Loi et al., 2016). 
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Distraction Osteogensis  
Distraction osteogenesis (DO) is a surgical technique where a transverse section 
of the bone is cut (an osteotomy), the two bone segments are then gradually separated, or 
distracted, and new bone forms within the gap between the segments (Salihan, 2007). The 
procedure is used to correct discrepancies in limb lengths, deformities, or bone defects 
(Sailhan, 2007). 
The DO procedure is typically divided into three separate phases: latency, active 
distraction, and consolidation. The latency phase, which lasts from the osteotomy until 
the beginning of distraction, allows for the initial response to trauma. This stage 
resembles those seen after fracture: inflammation and recruitment of mesenchymal stem 
cells (MSCs), upregulation of proinflammatory cytokines IL-1 and IL-6, TNF-β, as well 
as increased levels of BMP2 and BMP4, which stimulate differentiation of chondrogenic 
and osteogenic precursors (Al-Aql et al., 2008). 
During active distraction, longitudinal tensile forces are applied at a specific rate 
at regular intervals. This period is characterized by the formation of microcolumns—
“strands” of new bone oriented parallel to the direction of distraction that project from 
each side of the distracted bone fragments toward the center of the gap (Choi et al., 
2002). During active distraction, the osteotomy gap exhibits differences in structure and 
morphology, moving from the center of the osteotomy toward the native bone. The 
central fibrous tissue zone is characterized by mesenchymal proliferation and 
angiogenesis. There is an abundance of chondrocyte-like cells, fibroblasts, and oval cells. 
The zone of bone mineralization (or transition zone) contains differentiating osteoblasts 
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that are depositing osteoid along collagen bundles. In the bone remodeling zone, newly 
formed bone is remodeled by osteoclasts. The mature bone zone is the bone that similar 
in structure and appearance to non-distracted bone (Figure 1). 
 
Figure 1: Schematic of longitudinal section of bone during the phase of active distraction during DO. 
(1) Central Fibrous Zone: proliferation of mesechymal stem cells (MSCs), angiogenesis, and collagen 
bundle deposition, (2) Transition Zone: osteoid is secreted along collagen bundles, (3) Remodeling Zone: 
newly deposited bone is remodeled by osteoclasts, (4) Mature Bone Zone: bone is similar in structure and 
apperanace to adjacent undistracted bone. Figure taken from Seaward & Kane, 2013. 
 
Once the distraction phase has been completed, the consolidation phase begins, in 
which active distraction is discontinued. The distraction device remains fixed to the 
distracted bone segments to stabilize them in their final position. It is during this phase 
that new bone is allowed to mature and mineralize within the gap (Morcos, Al-Jallad, and 
Hamdy, 205; Natu et al., 2014). 
While typical fracture repair proceeds via endochondral ossification, three types 
of ossification have been identified during the process of DO. Endochondral ossification 
occurs during the latency phase, just as it does during the early stages of fracture repair. 
The consolidation phase is characterized by intramembranous ossification. A third 
mechanism of ossification has been identified histologically and has been characterized 
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by the formation of chondroid bone by “chondrocyte-like cells” with a gradual “transition 
from fibrous tissue to bone” (Sailhan, 2007). However, the predominant mechanism of 
ossification during DO is intramembranous ossification. This provides a unique model of 
studying bone modeling since most long bone formation occurs by endochondral 
ossification (Mackie et al., 2008). DO is an excellent model for post-natal bone 
generation without the addition of exogenous growth factors or materials 
 
The Role of Angiogenesis during Bone Repair 
VEGF is an endothelial cell (EC) survival and growth factor involved with 
maintaining and remodeling vasculature morphogenesis. It is thought that VEGF couples 
angiogenesis and osteogenesis during fracture repair. In particular, hypertrophic 
chondrocytes and osteoblasts secrete VEGF, which induces EC proliferation, migration, 
permeability, and ultimately stimulate vasculogenesis and angiogenesis (Clarkin and 
Gerstenfeld, 2012; Otrock et al., 2007). It has been demonstrated that osteoblasts 
proliferate and differentiate in response to VEGF signaling (Uttara, Piperni, and 
Catterjee, 2014). VEGF is involved in the recruitment and survival of both osteoblasts 
and osteoclasts (Street et al., 2002). VEGF expression and production by ECs and 
osteoblasts is stimulated by a variety of factors (e.g., pH, hypoxia, and other cytokines) 
and has autocrine and paracrine effects on ECs, osteoblasts, and osteoclasts (Figure 2) 
(Al-Aql, 2008).  
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Figure 2: Schematic of VEGF's effects on angiogenesis and osteogenesis. VEGF signaling induces 
processes related to both bone and vessel formation. It induces endothelial cell proliferation and promotes 
the formation of vasculature. Subsequently, it stimulates osteoblast differentiation. Figure taken from Yang 
et al., 2012  
 
The presence of vessels supply new bone with oxygen and other nutrients 
required for repair as well as osteoprogenitor cells (Adams & Alitalo, 2007). It has been 
suggested that the oxygen provided by local blood vessels induces mesenchymal stem 
cell differentiation toward bone formation during distraction osteogenesis (Pacicca et al., 
2003).  
Previous studies have characterized the vessel formation that occurs during DO. 
There is variability in both the temporal and spatial progression of the development of 
vasculature. During active distraction, arteriogenesis occurs in the surrounding muscle 
tissue followed by angiogenesis within the intraosteal region during consolidation 
(Morgan et al., 2012). Administration of TNP-470, an angiogenesis inhibitor, during 
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distraction osteogenesis caused disruption of angiogenesis, and subsequently, 
osteogenesis (Fang et al., 2005).  
In studies in which VEGF receptor 1 (VEGFR1) and 2 (VEGFR2) signaling was 
blocked by selective antibody antagonists, molecular analysis showed “significant 
inhibition in both vascular and skeletal cell development with both single and double 
antibody blockade of both VEGFR1 and 2” (Jacobsen et al., 2008). The single and double 
antibody treatments, however, produced different outcomes. While the single antibody 
treatment led to “selective early development of chondrogenesis,” the double antibody 
treatment caused “a failure of both osteogenesis as well as chondrogenesis” (Jacobsen et 
al., 2008). These findings showed that both VEGFR1 and VEGFR2 are necessary for the 
formation of both blood vessels and bone during DO and are required to promote an 
osteogenic lineage progression over a chondrogenic one (Jacobsen et al., 2008). It is clear 
that angiogenesis plays a critical role in osteogenesis, however, the mechanisms that 
underlie the relationship between the two processes are not well understood. 
 
Bone Morphogenetic Proteins 
Bone Morphogenetic Proteins (BMPs) belong to the Transforming Growth Factor 
β (TGF-β) superfamily that play a critical role in both embryonic development and post-
natally. BMPs regulate proliferation, differentiation, and maturation of many different 
cell types, including chondrocytes and osteoblasts, as well as the surrounding vasculature 
(David et al., 2009). BMPs signal through type I and the constitutively active type II 
Serine-Threonine Kinase receptors. Signaling is initiated by the binding of BMP to its 
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type II receptor follow by the recruitment and phosphorylation of the type I receptor 
forming a tetrameric receptor complex (Ogasawara et al., 2004, Rosen, 2009). The 
activated receptor complex then signals through either Smads-dependent and/or Smads-
independent pathways. 
 The canonical Smad-dependent signal is transduced by the activated type I 
receptor, phosphorylating and activating Smad 1,5, and 8, which are known as receptor-
regulated Smads (R-Smads) (Figure 3). These R-Smads then associate with Smad4 (Co-
Smad) and translocate to the nucleus where they act as transcription factors regulating the 
expression of their target genes, such as inhibitory differentiation factors 1 and 3 (ID-1, 
ID-3) and Runt-related transcription factor 2 (Runx2) (Rosen, 2009; David et al., 2009; 
Lissenberg-Thunnissen et al., 2011). ID-1 has been linked to bone mass while both ID-1 
and ID-3 are involved in angiogenesis (Lyden, 1999). Runx2 is a transcription factor that 
promotes the expression of osteogenic genes (Xu et al., 2015). BMP2 signals through the 
Smads pathways and subsequently affects these transcription factors, ultimately linking 
BMP2 signaling to both angiogenesis and osteogenesis.  
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Figure 3: Signaling pathways of Bone Morphogenetic Proteins. BMPs signal through multiple receptors 
and pathways. Also shown are mechanisms regulating BMP signaling at the cell surface (BAMBI) and 
extracellularly. Figure taken from van Wijk et al. 2007 	  
Multiple cell types associated with bone homeostasis including osteoblasts, and 
chondrocytes, as well as smooth muscle cells secrete BMPs (Bragdon et. al, 2011). In 
vitro studies showed prechondrocytes fail to differentiate into chondrocytes in the 
absence of functional BMP receptors (Enomoto-Iwamoto et al., 1998).  
Furthermore, altered or absent BMP signaling due to mutations in type II BMP receptors 
impairs angiogenesis and is observed in familial primary pulmonary hypertension (David 
et al., 2009; Lane et al., 2000).  
Bone Morphogenetic Protein-2 (BMP2) has an integral role in post-natal bone and 
cartilage formation as well as in fracture repair. During fracture repair, BMP2 is strongly 
expressed in periosteal cells and hypertrophic chondrocytes (Matsubara et al., 2012). The 
inactivation of BMP2 in a limb-specific manner in Prx+ cells led to spontaneous fractures 
due to decreased bone mineral density (Tsuji et al., 2006). Moreover, no initiation of 
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healing occurred at any point after fracture, despite the presence of mesenchymal 
progenitor cells. These cells were present at the site but remained undifferentiated. These 
results suggest that BMP2, specifically, is required for chondrocyte proliferation and 
maturation and therefore, the initiation of fracture repair (Tsuji, 2006). Similarly, 
osteoprogenitor cells in mice for which BMP2 expression was absent revealed that these 
cells lacked the ability to proliferate and differentiate into osteoblasts, suggesting that the 
absence of BMP2 stifles the progression from osteoprogenitor to osteocyte (Rosen, 
2009). 
In addition to BMP2’s multiple roles in bone homeostasis, development, and 
fracture repair, BMP2 is also involved with angiogenesis and proliferation of vascular 
tissues in human aortic endothelial cell in vitro (Eastell, Newman, and Crossman, 2010). 
Studies have shown that BMP2 induces pulmonary angiogenesis and the BMP type II 
receptor is required for BMP-mediated growth arrest and differentiation in pulmonary 
arteries (Perez, 2011; Yu et al., 2007). These findings suggest that the role of BMP2 is 
not limited to bone metabolism and repair, but also mediates vessel formation, and may 
play a role in coupling osteogenesis and angiogenesis. 
 
Role of BMP2 during Distraction Osteogenesis 
Further evidence to support the hypothesis that BMP2 couples post-natal bone 
formation and angiogenesis is the DO model. BMP2 induces differentiation and 
proliferation of cells within and surrounding the distraction gap. However, BMP2 is 
primarily expressed in vascular tissues with alternating spatial and temporal expression 
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patterns (Matsubara et al., 2012). Initially, BMP2 expression is increased within the 
musculature surrounding the distraction gap possibly increasing endothelial cell survival, 
proliferation, and migration for new vessel formation. It also serves as means to regulate 
proliferation of smooth muscle cells. During active distraction, BMP2 expression 
decreases in the musculature. Both bone and muscle tissues begin to resemble their 
appropriate shape and an increase in vessel thickness occurs. Subsequently, BMP2 
expression within the distraction gap increases. Small vessels invade the gap and growth 
of capillaries is observed. These developments promote MSCs to undergo osteogenic 
differentiation. Lastly, during consolidation, BMP2 expression levels increase in the 
muscle. This coincides with the formation of new, small vessels in the extraosteal space 
(Matsubara et al., 2012). 
 
Experimental Aims 
Studies have shown the alternating spatial and temporal expression of BMP2 in 
musculature surrounding the distraction gap during DO. The current project focuses on 
the role of BMP2 in angiogenesis during DO and mechanism by which BMP2 mediates 
crosstalk during bone repair. 
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METHODS 
Animal Model 
A transgenic mouse developed by Dr. Steve Harris was used for this study (Yang 
et al., 2012). A SMA-Cre ERT was crossed with a with BMP2 flox/flox in order to 
achieve an inducible conditional knockout of BMP2 in SMA positive cells (BMP2-cKO). 
Conditional inducible knockouts were required due to embryonic lethality of traditional 
genetic BMP2 knockouts (Bragdon et al., 2011). Two strains were used for barium-
gelatin perfusion and subsequent µCT scanning and analysis. These were the dTomato x 
SMAcre x BMP2 flox and the LacZ x SMAcre x BMP2 flox. The difference between 
these two strains is the reporter (dTomato and LacZ). The strain used for histology to 
identify the SMA cre positive cell population was the SMA Cre x LacZ. Animals used for 
histological analysis of BMP2 expression expressed the reporter gene, lacz. These 
animals were B6;129S4-Gt(ROSA)26Sortm1Sor/J crossed with SMA-Cre animals. 
The resulting strain was an SMA Cre-Lacz strain. 
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List of Reagents Used 
Table 1: Common reagents and equipment used for this study. 
Reagents  Manufacturer  
Phosphate buffered saline (PBS) Applied BiosystemsTM  
Enrofloxacin  Baytril®  
Povidone-iodine  Betadine®  
Buprenorphine  Buprenex®  
Barium sulfate (Catalog No: 764)  E-Z-EM Canada Inc.  
10% Phosphate buffered formalin, NaOH 
pellets, TAE buffer  Fisher Scientific
TM  
Isoflurane  Henry Schein®  
Agarose, Chloroform, Ethanol, 
Ethylenediaminetetraacetic acid (EDTA),  Sigma-Aldrich
®  
Gelatin, Hydrochloric Acid (HCl), 
Isopropanol, Paraformaldehyde (PFA), and 
Tamoxifen 
 
 
Distraction Osteogenesis Surgical Procedure  
All surgical procedures occurred under an IACUC approved protocol. All surgery 
was performed under general anesthesia using Isoflurane. Prior to the initiation of 
surgery, mice were given an subcutaneous injection of Baytril®  (0.01mL) for infection 
prophylaxis and Buprenex®  (0.1mL) for post-operative analgesia. A longitudinal 
incision was made along the axis of the left femur. The femur was isolated from the 
surrounding muscle and tissue while the distraction device was fastened to the femur 
using 0.012 inch wires. Once the device was secured to the femur, a transverse osteotomy 
is made between the arms of the device. 
Fascia was sutured with absorbable C-3 6-0 surgical plain gut and the skin was 
closed with absorbable C-1 5-0 surgical plain gut. Post-surgical weight was recorded for 
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each animal and animals were monitored and treated twice daily with Buprenex and 
Baytril for 48 hours post-surgery. Animals were able to walk and bear weight on the limb 
upon awakening from anesthesia.  
  
Distraction Procedure 
Surgery on day 1 is followed by a latent period of 7 days. Beginning on post-
operative day (POD) 7, the period of active distraction was initiated. Distraction was 
carried out twice a day for 10 days. Each distraction was one quarter turn of the 
distraction device, resulting in a distraction distance of 0.15mm/day. The active 
distraction period of 10 days results in an overall distraction distance of 1.5mm. Animals 
were sacrificed and femurs were harvested at two time points: day 17 (10 days into active 
distraction) and day 31 (end of consolidation).  
 
Tamoxifen Preparation and Injections  
Tamoxifen was dissolved in corn oil (10mg/mL) by sonication until all solid was 
dissolved. The solution was sterile filtered with (0.22µm) exclusion filter, aliquoted, and 
stored at -80ºC. Tamoxifen was administered according to body weight (0.01mL/gram 
mouse) to mice by intraperitoneal (IP) injections at POD 6 and continued three times per 
week through the experiment. Femurs were harvested at POD 17 and 31. Vehicle 
injections of corn oil were used as control and followed the same regimen of injections as 
tamoxifen.  
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Barium Perfusion Procedure 
Animals were euthanized using CO2 followed by thoracotomy. Prior to perfusion, 
X-rays of the distracted limb were collected using the Faxitron® MX-20 Specimen 
Radiography System at 30kV for 40 seconds at a distance of 15 cm. 
Animals were placed supine on a styrofoam tray. An initial incision was made just 
beneath the rib cage, followed by a small incision in the diaphragm, separating the 
diaphragm from the rib cage. The incision in the diaphragm is continued up the midline 
through the rib cage and the pleural cavity is exposed (Figure 4). The ribcage was pinned 
back. 
	  
Figure 4: Incisions performed prior to perfusion fixation. With the mouse in a supine position, an initial 
incision is made beneath the rib cage. The diaphragm is separated from the rib cage and the pleural cavity 
is exposed. Figure taken from Gage, Kipke, Shain, 2012. 
A 25 gauge butterfly needle (BD®) was inserted into the left ventricle and 
secured with All Purpose Krazy Glue® (Toagosei Company, Ltd.). Animals were first 
perfused with 10mL of 10% phosphate buffered formalin solution to both flush the 
circulatory system and maintain patency of the vasculature. Subsequent to this perfusion, 
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the vasculature was then filled with 6mL of barium only solution and 10mL of the 
barium-gelatin solution. 
The barium-gelatin solution was created by melting 1.2g of gelatin in 4 mL of 1x 
PBS. A solution of 6 mL of Barium (98% w/w) was added to gelatin and kept warm with 
a hot water bath for at least 40 minutes. 
After perfusion, both the distracted and contralateral femurs were harvested and 
placed in 4% PFA for tissue fixation for three days. Samples were subsequently stored in 
PBS at 4ºC until they were imaged. 
 
MicroCT40 Scanning 
Prior to scanning, wires were threaded through samples to be used as position 
reference points and embedded in 2% agarose. The scanned region included the femur 
and was approximately 1200 slices, but the number of slices varied slightly between 
samples due to the differences in orientation of the femur within the scanner tube. 
Predetermined settings for X-ray beam energy and intensity, resolution, measurement 
time, and density calibration were determined and saved as a control file, which in this 
study was “DBM_Vessels” to ensure consistency and reliable comparison between 
results. The settings in this study were 70kV for voltage, 114 mA for current, and 300 
seconds of integration time. 
After scanning, samples were decalcified with 14% EDTA for approximately 10 
days at 4ºC and the region was rescanned used the metal wire as reference. Pre- and post-
decalcified scans were contoured to include the bone, vessels, and surrounding tissue. 
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These scans were converted to DICOM files and used for image co-registration in 
AMIRA®.  	  
Image Registration in AMIRA® 
Following scanning, the calcified and decalcified scans of each sample were 
transferred into AMIRA® (FEI Software). During the process of decalcification, tissues 
can undergo considerable structural deformation. Using the AMIRA® software, the 
decalcified scan (containing only vessels) was registered to landmarks on the calcified 
scan (containing bone and vessels). The bone was aligned anatomically and the extent of 
vessel formation around the distraction gap could be analyzed. Co-registration of pre- and 
post-decal scans “restored the original anatomic arrangement of the vasculature in the 
post-decal scans, thereby enabling regional analysis of the vessel elements and co- 
localization of vessels and mineralized tissue” (Morgan et al., 2012). 
Prior to evaluation in Scanco®, the region of interest was defined to include the 
distraction gap and the transition between newly formed bone and native bone. The 
region of interest was between 250 and 500 pixels along the length of the femur for all 
samples depending on the alignment of the distracted bones.  
 
Bone Tomography Evaluation 
After co-registration of the pre- and post-decalcified images, the threshold was 
determined for each sample based on the post-decal scan (see appendix for commands). 
An evaluation of Bone Trabecular Mophometry (#5) was run, giving an initial estimation 
of bone morphometric parameters. Component labeling of the vessels was performed in 
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order to reduce any remaining noise by categorizing all segmented objects according to 
their size. Islands of disconnected vessels that did not meet minimum size criteria were 
removed. The settings for image filtering, support and sigma, were adjusted to 2 and 4, 
respectively, to reduce noise in the images. 
Following component labeling of the vessels, manual evaluations of vessel 
volume, vessel number, and vessel thickness were run at the appropriate, sample-specific 
threshold (See Appendix). 
 
Histological Analysis 
Samples were fixed 4% paraformaldehyde (PFA) for 1 hour in 20mL conical tubes. The 
samples were then washed three times in X-gal wash buffer (MgCl2, Deoxycholic acid, 
Nodidet P-40, Monobasic sodium phosphate pH 7.3, Dibasic sodium phosphate pH 7.3, 
dH2O) for 30 minutes. The wash buffer was removed and X-gal stain (X-gal in DMF, K-
ferrocyanide, K-ferricyanide, Tris pH 7.5, Wash Buffer)was added to each of the 
samples. The conical tubes were covered in aluminum foil to reduce exposure to light and 
stored in the 4˚C freezer for 1-2 days. After staining, the samples were washed with 1x 
phosphate buffered saline (PBS) three times for 30 minutes each. Samples were then 
decalcified in EDTA (14% w/v) and stored in 4˚C until processed for paraffin 
embedding. Samples were sectioned longitudinally along the axis of the femur in 5µm 
increments. Samples were then de-paraffined, dehydrated, and stained with eosin 
(Matsubara et al., 2012). 
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RESULTS 
Cre-loxP System 
Cre recombinase is an enzyme that binds to the recombinase binding element 
(RBE) and catalyzes recombination between two lox P sites flanking the gene of interest. 
This study used a tamoxifen inducible cre-lox transgenic mouse model where Cre 
recombinase fused with the mutated estrogen receptor (SMA Cre ERT) was driven by the 
SMA promoter and BMP2 was floxed. This resulted in the inducible deletion of BMP2 in 
vascular smooth muscle cells (Figure 5). This transgenic mouse model will be referred to 
as BMP2-cKO. 
The SMA Cre ERT mouse was also crossed with the B6;129S4-
Gt(ROSA)26Sortm1Sor/J reporter mouse. The reporter mouse, B6;129S4-
Gt(ROSA)26Sortm1Sor/J, possesses similar lox-P sequences flanking a stop codon 
preventing the transcription of LacZ. Expression of Cre leads to the removal of a stop 
codon allowing for expression of LacZ. This model allows for the identification of cell 
populations in which BMP2 is being conditionally deleted by histological analysis.  
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Figure 5: Schematic of transgenic mouse model. The cre-loxP system can be utilized in specific cell 
types by introducing cell or tissue-specific promoters. In this study, the promoter for smooth muscle actin 
positive cells was utilized upstream of the gene encoding the Cre recombinase enzyme. This promoter was 
inducible by introducing tamoxifen. The floxed target gene is BMP2. When the mice are crossed, the 
resulting animal strain is an SMA x BMP2 flox. Figure taken from Stricklett, Nelson, and Kohan, 1999. 
 
The DO procedure was performed on BMP2-cKO mice. Tamoxifen was 
administered to induce cre activity at post-operative day 6 and continued throughout the 
experiment. Active distraction started at day 7 and ended at day 17. Tissue was collected 
at the end of distraction, day 17 and at the end point, day 31. Samples were stained for 
LacZ activity, embedded and sectioned. Histological analysis showed that LacZ was 
found in endothelial cells of small vessels, skeletal muscle, smooth muscle, and 
chondrocytes (Figures 6 and 7).  
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Figure 6: LacZ expression indicating knockout of BMP2 expression at POD 17. (A) Overview of 
longitudinal section along the axis of the femur LacZ expression is seen in tissues and cells surrounding the 
distraction gap including (B) endothelial cells (C) osteocytes, and (D) chondrocytes. 
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Figure 7: LacZ expression indicating knockout of BMP2 expression at POD 31. (A) Overview of 
longitudinal section along the axis of the femur LacZ expression is seen in tissues and cells surrounding the 
distraction gap including (B) chondrocytes and osteocytes, (C) endothelial cells, (D) osteocytes and (E) 
skeletal muscle. 	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X-Ray  
The extent of bone formation in both the control and BMP2-cKO was initially 
assessed by radiograph. X-rays were taken after animals were euthanized but prior to the 
removal of the distraction device from the femur. The images in Figure 8 are 
representative of their respective experimental condition and time point.  
 At the end of active distraction and beginning of consolidation (POD 17), the 
BMP2-cKO animals showed decreased bone formation within the distraction gap 
compared to the control animals. At POD 31, which is the end of the consolidation 
period, both groups showed an increase in bone formation compared to POD17. There 
appeared to be a continued decrease of bone in the BMP2-cKO compared to the control. 
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Figure 8: DO X-ray results. X-ray results at day 17 (top row) and day 31 (bottom row) for control and 
BMP2-cKO animals. The control animals received corn oil injections and the experimental group received 
tamoxifen (10mg/mL). These images are representative of all DO procedures. 
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µCT Evaluations 
 Control 
 Full Image Distraction Gap 
Day 
17 
 
 
Day 
31 
 
 
Figure 9: Anterior views of co-registered bone and vessels femurs from control animals. The anterior 
view of the femur (left column) and surrounding vessels. The region of interest was defined as the 
distraction gap and included transition back to native bone (right column). The top row shows animals 
harvested at day 17 while the bottom row showed animals harvested at day 31. 
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 BMP2-cKO 
 Full Image Distraction Gap 
Day 
17 
 
 
Day 
31 
 
 
Figure 10: Anterior views of image co-registration bone and vessels from BMP2-cKO animals. The 
anterior view of the femur (left column) and surrounding vessels. The region of interest was defined as the 
distraction gap and included transition back to native bone (right column). The top row shows animals 
harvested at day 17 while the bottom row showed animals harvested at day 31. 
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Vessel formation, size, number, and morphology were evaluated using manual 
Scanco® commands. Vessel volume is a measure of the total volume of the vessels 
contained within the sample. Vessel number and vessel thickness are measures of the 
quantity and size and thickness of the vasculature.  
Before evaluations were run, component labeling was performed. Component 
labeling of the vessels was performed in order to reduce any remaining noise by 
categorizing all segmented objects according to their size. Any islands of disconnected 
vessels that did not meet a minimum size criteria were removed (Figure 11). 
Figure 11: Comparison of vessels prior to (left) and after (right) component labeling. Component 
labeling categorizes segmented objects based on size. Disconnected segments (circled) that do not meet a 
minimum size criteria are removed, resulting in the image on the right. 
 
The vessel volume at day 17 was 0.815mm3 and decreased to 0.552mm3 at day 31 
for the controls. The BMP2-cKO did not show a change in vessel volume across time. 
There was a decrease of vessel volume in the BMP2-cKO at day 17 and day 31 compared 
to the controls (Figure 12).  
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Figure 12: Volume of vessels (in mm3) surrounding distraction gap. The sample size for POD for day 
17 is n=2 and the samples size for POD 31 is n=3. The error bars shown are standard deviation.  	  
Overall, vessel thickness decreased between day 17 and day 31 for both control and 
tamoxifen treated animals. The BMP2-cKO, vessel thickness was also decreased 
compared controls at both time points (Figure 13).  
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Figure 13: Thickness of vessels (in mm) surrounding the distraction gap. The sample size for POD for 
day 17 is n=2 and the samples size for POD 31 is n=3. The error bars shown are standard deviation. 
 
Control animals showed little difference in vessel number per unit length between day 17 
and day 31. BMP2-cKO animals, however, showed an increase in vessel number per unit 
length between the two time points (Figure 14). 	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Figure 14: Number of vessels per unit length (1/mm) surrounding the distraction gap. The sample size 
for POD for day 17 is n=2 and the samples size for POD 31 is n=3. The error bars shown are standard 
deviation. 
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DISCUSSION 
The x-ray results show bone is forming within the distraction gap at day 17, the 
end of active distraction and beginning of consolidation for both control and BMP2 
knockouts. The controls animals, however, show a greater extent of bone formation 
within the distraction gap than the BMP2-cKO animals. At day 31, which marks the end 
of consolidation, both groups showed an increase in bone formation, though differences 
in the extent of consolidation is not easily discernable between control and BMP2-cKO 
animals.  Therefore, BMP2 may have more significance on bone formation earlier in 
bone formation since the extent of bone formation is greater in the control mice at day 17. 
Similarly, the role of BMP2 in bone and vessel formation may diminish over time after 
injury or DO, suggesting that its temporal expression affects the rate or extent of healing.  
The results of the microCT evaluations show that there is a difference in vessel 
volume, number, and thickness both between experimental conditions as well as in post-
operative day. The largest differences are seen in vessel volume and thickness, in which 
the BMP2-cKO animals exhibited comparably lower values than the control animals. 
There was not a significant	  difference in vessel number for the control animals between 
day 17 and day 31, however, the BMP2-cKO showed an increase in vessel number. The 
component labeling helped reduce noise and produce an image with “cleaner” vessels. 
Since only the smallest islands were removed, this would not dramatically affect the 
computed vessel volume. It might, however, have a greater effect on the number of 
vessels since the component labeling removes discrete segments that do not meet a 
certain size criteria. 
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The variability may be due to multiple reasons including a small sample size (n=2 
and n=3 for days 17 and 31, respectively). The perfusion procedure itself also has some 
variability. Perfusing with an antibody that will delineate the vessels instead of the 
barium-gelatin solution may help resolve some of this variability, however, doing so 
would not allow for microCT analysis. In addition, the region of interest, which included 
the distraction gap, was determined for each individual sample. Because of the nature of 
the procedure, removal of the distraction devices may have disrupted the final position of 
the separated bone segments. This ultimately, would contribute to differences in the size 
of the region of interest despite the fact that distraction distances were equivalent for all 
day 17 and day 31 animals. These issues could be resolved by leaving the implant 
attached to the femur after harvest or by using a permanent implant that is fixed directly 
to the femur.  
From the histology, there were SMA positive cells in the tissues surrounding the 
distraction gap. LacZ expression indicates SMA positive cells. Endothelial cells in 
capillaries, smooth muscle, skeletal muscle, and chondrocytes expressed the reporter 
gene. However, the presence of LacZ in skeletal muscle suggests that the targeting is not 
exclusively restricted to smooth muscle cells. This was also observed in Grcevic et. al 
(2012), in which the SMA positive cell population exhibited characteristics of 
mesenchymal progenitor cells. Tamoxifen injections began at day 6, prior to the 
beginning of active distraction, in an effort to target vascular smooth muscle cells, rather 
than osteogenic progenitors. It was thought that by day 6 the osteoprogenitor cells 
recruited for bone repair would have committed to a specific osteogenic lineage. It can be 
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inferred from the histological results that BMP2 may be knocked out in not only smooth 
muscle, but in other tissue types as well. 
These results have clinical implications. BMP2 has a potential use for fracture 
healing, particularly during consolidation. It could be used as a supplement to help aid 
fracture healing by increasing both bone and vessel formation. Similarly, BMP2’s 
angiogenic properties alone may help restore damaged vasculature after traumatic injury 
or invasive surgical procedures. 
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APPENDIX 
 
Scanco Evaluation Commands 
Threshold Determination 
ipl > adapt_iter 	  
 
Manual Evaluations 
ipl> cl_nr_extract 
 
ipl> write 
 
For vessel volume: 
ipl> /vox_scanco_param 
 
 
For vessel thickness: 
ipl> /dt_object_param 
 
For vessel number: 
ipl> /dt_mat_param 
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